NCT07099105Completed
Subcostal Single-port Versus Intercostal Multi-port Robotic Lobectomy for Non-small Cell Lung Cancer
Subcostal Single-port Versus Intercostal Multi-port Robotic Lobectomy for Non-small Cell Lung Cancer: A Single-centre Retrospective Propensity Matched Study
Source: ClinicalTrials.gov · Last updated 1 Aug 2025
Brief summary (registry, in English)
The goal of this observational study is compared the perioperative outcomes of robotic lobectomy using the SP system via the subcostal approach with those of multi-port robotic lobectomy using the Xi system via the intercostal approach.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 339 (actual)
- First submitted
- 23 Jul 2025
- Start date
- 1 Jan 2017
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Korea University Guro Hospital
- Diseases
- Lung cancer
- NCT number
- NCT07099105
What you commit to
- Study type: Observational
- Participants enrolled: 339
- From 1 Jan 2017 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- patients who underwent Viedo-assisted thoracic surgery lobectomy
- patients who underwent robotic lobectomy with other combined surgery
- patients who received neoadjuvant therapy
Who the study is looking for
- patients aged \> 18 years who underwent RATS lobectomy for NSCLC at the Korea University Guro Hospital between January 2017 and December 2024
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Korea University Guro Hospital Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.